MAM
VNDA icon

Meeder Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Meeder Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,852
Closed -$31.5K – 1011
2025
Q1 		$31.5K Hold
6,852
– – ﹤0.01% 461
2024
Q4 		$32.8K Hold
6,852
– – ﹤0.01% 440
2024
Q3 		$32.1K Hold
6,852
– – ﹤0.01% 432
2024
Q2 		$38.7K Buy
+6,852
New +$35.4K ﹤0.01% 386
2022
Q4 		– Sell
-154
Closed -$2K – 1987
2022
Q3 		$2K Buy
154
+39
+34% +$412 ﹤0.01% 1870
2022
Q2 		$1K Buy
115
+49
+74% +$508 ﹤0.01% 2093
2022
Q1 		$1K Buy
+66
New +$868 ﹤0.01% 2257
2021
Q4 		– Sell
-4,435
Closed -$77K – 2315
2021
Q3 		$77K Buy
4,435
+4,322
+3,825% +$75.7K ﹤0.01% 975
2021
Q2 		$2K Sell
113
-880
-89% -$15.7K ﹤0.01% 2262
2021
Q1 		$14K Buy
993
+970
+4,217% +$15.7K ﹤0.01% 1522
2020
Q4 		$0 Sell
23
-5,638
-100% -$67.9K ﹤0.01% 2239
2020
Q3 		$55K Buy
5,661
+2,502
+79% +$26.7K ﹤0.01% 938
2020
Q2 		$36K Buy
3,159
+2,259
+251% +$25.6K ﹤0.01% 992
2020
Q1 		$9K Sell
900
-9,666
-91% -$120K ﹤0.01% 1582
2019
Q4 		$173K Buy
10,566
+5,351
+103% +$80.9K 0.01% 639
2019
Q3 		$69K Buy
5,215
+4,915
+1,638% +$68.5K ﹤0.01% 909
2019
Q2 		$4K Sell
300
-7,992
-96% -$127K ﹤0.01% 1744
2019
Q1 		$153K Buy
8,292
+174
+2% +$3.96K 0.01% 601
2018
Q4 		$211K Sell
8,118
-3,299
-29% -$77.6K 0.02% 487
2018
Q3 		$261K Buy
11,417
+7,102
+165% +$145K 0.02% 461
2018
Q2 		$82.2K Buy
4,315
+1,293
+43% +$21.6K 0.01% 659
2018
Q1 		$50K Sell
3,022
-453
-13% -$7.58K ﹤0.01% 676
2017
Q4 		$53K Buy
3,475
+523
+18% +$7.76K ﹤0.01% 679
2017
Q3 		$53K Buy
2,952
+1,867
+172% +$31.2K 0.01% 676
2017
Q2 		$18K Buy
+1,085
New +$15.6K ﹤0.01% 850

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Meeder Asset Management's VNDA Position: Q2 2025 in Review

Meeder Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q2 2025, closing a stake of 6,852 shares — an estimated $31.5K sold.

Meeder Asset Management first reported a position in VNDA in Q2 2017 and held it in 25 quarters. The position peaked at $261K in Q3 2018. 139 funds tracked by Wall St. Rank hold VNDA as of Q2 2025.

  • Meeder Asset Management reported no remaining Vanda Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Meeder Asset Management sold 6,852 Vanda Pharmaceuticals shares in Q2 2025, an estimated $31.5K.
  • Meeder Asset Management first reported a position in Vanda Pharmaceuticals in Q2 2017 and held it in 25 quarters.
  • Meeder Asset Management's Vanda Pharmaceuticals position peaked at $261K in Q3 2018.
  • 139 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2025.

Based on Meeder Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.